AtaCor is a medical device company pioneering new approaches to extravascular cardiac rhythm management.
atacor.com
San Clemente, CA
CEO: Rick Sanghera
Arboretum Lead: Jan Garfinkle
AtaCor Medical
IN THE NEWS
AtaCor Medical Announces First Patient Treated Globally in its ALARION-EV Pivotal Trial
AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced today the enrollment of the first patient in the company's ALARION-EV study (NCT07324031).
Read More
Abbott and AtaCor Medical Collaborate on Advanced Extravascular ICD Technology
Abbott today announced a collaboration with AtaCor Medical to advance a next-generation investigational extravascular implantable cardioverter defibrillator (EV-ICD) system designed to deliver defibrillation therapy to people with life-threatening heart rhythms.
Read More
AtaCor Medical Secures $75M Financing to Support the Pivotal U.S. Study of its Extravascular ICD (EV-ICD) System
AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management systems, announced today that it has entered into a financing of up to $75 million.
Read More
